AI chatbot coaches teens through anxiety homework

NCT ID NCT07666672

Not yet recruiting Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests BraveBot, a computer program that talks with young people (ages 12-22) through their phone or computer while they do exposure therapy homework for anxiety or OCD. BraveBot does not replace the therapist but offers real-time coaching and encouragement during assigned exercises. The goal is to see if using BraveBot helps youth understand their homework better, put in more effort, and feel more capable of handling anxiety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BraveBot (a GPT-powered audio-to-audio conversational assistant delivered via SMS)
What this could lead to: If it works, BraveBot could make exposure therapy homework more effective and easier for young people to stick with, potentially improving anxiety treatment outcomes.
What could go wrong: This is a small, early-stage study with only 50 participants, and it randomizes individual homework assignments rather than comparing groups, so results may not generalize widely. The tool is not a replacement for therapy and may not help everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder obsessive-compulsive disorder obsessive-compulsive personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DISORDERS OCD

Contacts and locations

Locations

Harvard University

Cambridge, Massachusetts, 02138, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
McLean Hospital

Belmont, Massachusetts, 02478, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.